Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Aspira Pathlab and Diagnostics Ltd

Your Vote -

Buy

66.67%

Hold

0.00%

Sell

33.33%

66.67%

3 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Aspira Pathlab and Diagnostics Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Aspira Pathlab & Dia - Re-Appointment Of Dr. Pankaj Shah (DIN: 02836324) As Managing Director & CEO Subject To The Members Ap

    16 May 2025, 9:05PM Re-appointment of Dr.Pankaj Shah (DIN:02836324) as Managing Director & CEO subject to the members approval for a period of three (3) years i.e from Au
  • Aspira Pathlab & Dia - Intimation Of Appointment Of Secretarial Auditor And Internal Auditor

    16 May 2025, 8:55PM Appointment of Secretarial Auditor and Internal Auditor of the Company
  • Aspira Pathlab & Dia - Integrated Filing (Financial)

    16 May 2025, 8:29PM Integrated Financial Results as on March 31, 2025
  • Aspira Pathlab & Dia posts Q4 net profit of Rs 0.72 cr

    16 May 2025, 8:10PM The company reported standalone net profit during the quarter stood at Rs 0.72 crore compared to net loss of Rs 0.50 crore in the previous year quarte
  • Aspira Pathlab & Dia - Board Meeting Outcome for Outcome Of The Board Meeting Dated May 16, 2025

    16 May 2025, 8:09PM Outcome of the Board Meeting dated May 16, 2025
  • Aspira Pathlab & Dia - Board Meeting Outcome for Outcome Of The Board Meeting Dated May 16, 2025

    16 May 2025, 8:08PM Outcome of the Board Meeting dated May 16, 2025
  • Aspira Pathlab & Dia - Board Meeting Intimation for Approval Of Audited Standalone & Consolidated Financial Results Of The Co

    7 May 2025, 5:15PM Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2025 ,inter alia, to
  • Aspira Pathlab & Dia - Updation In Contact Details Of The Company Registrar And Share Transfer Agent

    22 Apr 2025, 1:39PM Updation in Contact Details of the Company Registrar and Share Transfer Agent
  • Aspira Pathlab & Dia has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    16 Apr 2025, 1:12PM As of March 2025, 18.39% is owned by Indian Promoters and 81.61% by Public. <p align=justify> Top four Promoters holding highest number of shares of A
  • Aspira Pathlab & Dia - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2

    15 Apr 2025, 1:46PM <b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border='1px'> <tr> <td><b>Sr
  • Aspira Pathlab & Dia - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

    15 Apr 2025, 1:23PM <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border='1px'><tr> <td><b>Sr. No.</b></td
  • Aspira Pathlab & Dia - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    9 Apr 2025, 4:13PM Compliance Certificate in accordance with regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 3
  • Aspira Pathlab & Dia - Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015

    8 Apr 2025, 7:24PM Announcement as per regulation 30 of the SEBI (LODR) Regulations, 2015

Key fundamentals

Evaluate the intrinsic value of Aspira Pathlab and Diagnostics Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 13.4228 11.2205 13.7122 13.6482 9.5651
Liabilities 13.4228 11.2205 13.7122 13.6482 9.5651
Equity 10.293 10.293 10.293 10.293 10.293
Gross Profit 3.5249 -1.1868 1.5932 6.3731 3.5132
Net Profit 2.0726 -2.6722 -0.0887 4.4594 1.381
Cash From Operating Activities 1.8769 1.053 -0.0121 2.031 5.6734
NPM(%) 9.42 -20.23 -0.61 22.81 9.08
Revenue 21.999 13.2049 14.4569 19.5419 15.2054
Expenses 18.4741 14.3917 12.8637 13.1688 11.6922
ROE(%) 17.03 -21.96 -0.72 36.65 11.35

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Aspira Pathlab and Diagnostics Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 810.05 -1.12 26.88 33.50 301.39 0.62
Lotus Eye Hospital and Institute Ltd 74.39 0.39 308.58 122.07 14.01 0.68
Bharat Immunological and Biologicals Corporation Ltd 25.66 -5.45 0.00 253.47 -39.50 0.00
Astec Lifesciences Ltd 698.00 -1.87 0.00 115.11 -687.11 0.00

Company Info

Aspira Pathlab & Diagnostics Ltd. Was incorporated as 03td July in the year 1973 in the name of 'industrial Gas & Steel Products (India) Ltd.' It has changed its name to 'Utkal Soap Products Ltd.' on 4th February, 1980. USPL with the main object of dealing in gases Products & Steel Products, Subsequent to change of name of the Company, it has changed its object in 1980 to manufacture laundry soaps for Hindustan Lever Limited, having its factory at Sambalput - Orissa. the Company has stopped Manufacturing production since November, 2004 as the job work for Hindustan Lever Limited was not renewed because of additional duties levied by the Government, it has became unviable proposal & the Company has disposed off all its assets in 2005. The employees have been paid off their dues as per settlement with the Labour union, Since 2005.The Company has changed its object clause on 10th August, 2016 & Ventured into diagnostic centers laboratories etc, & stated generating income from December, 2016 onwards. The Company changed its name to 'Aspira Parthlab & Diagnostics Ltd.' on 16th November, 2016.

Aspira Pathlab & Diagnostics Ltd. Was incorporated as 03td July in the year 1973 in the name of 'industrial Gas & Steel Products (India) Ltd.' It has changed its name to 'Utkal Soap Products Ltd.' on 4th February, 1980. USPL with the main object of dealing in gases Products & Steel Products, Subsequent to change of name of the Company, it has changed its object in 1980 to manufacture laundry soaps for Hindustan Lever Limited, having its factory at Sambalput - Orissa. the Company has stopped Manufacturing production since November, 2004 as the job work for Hindustan Lever Limited was not renewed because of additional duties levied by the Government, it has became unviable proposal & the Company has disposed off all its assets in 2005. The employees have been paid off their dues as per settlement with the Labour union, Since 2005.The Company has changed its object clause on 10th August, 2016 & Ventured into diagnostic centers laboratories etc, & stated generating income from December, 2016 onwards. The Company changed its name to 'Aspira Parthlab & Diagnostics Ltd.' on 16th November, 2016.

Read More

Parent Organisation

Aspira Pathlab & Diagnostics Ltd.

Founded

03/07/1973

Managing Director

Dr.Pankaj J Shah

NSE Symbol

FAQ

The current price of Aspira Pathlab and Diagnostics Ltd is

The 52-week high for Aspira Pathlab and Diagnostics Ltd is

The market capitalization of Aspira Pathlab and Diagnostics Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Aspira Pathlab and Diagnostics Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Aspira Pathlab and Diagnostics Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Aspira Pathlab and Diagnostics Ltd shares.

The CEO of Aspira Pathlab and Diagnostics Ltd is Dr.Pankaj J Shah, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT